Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Prosthetic Heart Valve Market Outlook

With a projected global Prosthetic Heart Valve Market size of US$ 13,234.9 million by 2023, the industry is anticipated to advance rapidly. By 2033, the prosthetic heart valve market is expected to be valued at US$ 27,277.6 million.

The prosthetic heart valve sales are set to rise through 2033 at a CAGR of 7.5% due to the increased prevalence of valvular illnesses like tricuspid regurgitation, idiopathic and ischemic mitral regurgitation, and aortic stenosis.

Attributes Details
Market Value for 2023 US$ 13,234.9 million
Market Value for 2033 US$ 27,277.6 million
Market CAGR from 2023 to 2033 7.5%

Catalysts for Market Growth of Prosthetic Heart Valve

  • As the world's population ages, valvular heart diseases, frequently necessitating heart valve replacement, occur more regularly. The demographic transition significantly compels the demand for prosthetic heart valves.
  • Government organizations and regulatory authorities worldwide have set standards and approval procedures to guarantee the safety and effectiveness of prosthetic heart valves. The regulatory frameworks boost patient and professional confidence, which fosters market expansion for prosthetic heart valves.
  • Advanced surgical techniques have become readily accessible since advancements in healthcare infrastructure, particularly in emerging nations. Since patients can now undergo therapy, this has benefited the prosthetic heart valve sector.
  • Research and development efforts in cardiology and cardiac surgery have produced cutting-edge heart valve technologies, including tissue-engineered heart valves, which may propel market expansion for prosthetic heart valves.

Innovative Opportunities in the Prosthetic Heart Valve Sector

  • Increasingly, more people are choosing to get minimally invasive surgery. Growth opportunities for prosthetic heart valves may be opened, and patient outcomes can be enhanced by creating prosthetic heart valves appropriate for less intrusive operations.
  • The prosthetic heart valve market may grow due to improved patient education and awareness, resulting in earlier diagnosis and treatment.
  • Heart valve problems become increasingly familiar with age, and the world's population is aging. This demographic shift opens up a sizable market for manufacturers of prosthetic heart valves.
  • Rapid market expansion is seen in transcatheter aortic valve replacement (TAVR). TAVR is a less intrusive option when replacing an aortic valve than open heart surgery. The opportunity for business growth that develops and promotes transcatheter aortic valve replacement devices is substantial.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

A Historical Perspective of Prosthetic Heart Valve Market from 2018 to 2022 and Forward Gaze from 2023 to 2033

Artificial Heart Valve Market Overview from 2018 to 2022

  • The prosthetic heart valve market grew consistently. Aging populations globally, a spike in heart valve problems, and technological medical advances were the primary catalysts of the growth.
  • The transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) techniques showed significant adoption. Less traditional open-heart surgery was required as the minimally invasive treatments spread in popularity.
  • Regulatory bodies, necessitating investments in research and development for prosthetic heart valves, enforced stricter quality and safety requirements.
Historical CAGR 11.9%
Forecast CAGR 7.5%

Predictions and Potential Developments from 2023 to 2033

  • An aging population and progressive heart valve illnesses may contribute to market growth for prosthetic heart valves.
  • As healthcare infrastructure develops and more people have access to cutting-edge medical procedures, emerging nations may experience a surge in demand for prosthetic heart valves.
  • Costs for prosthetic heart valves may decrease as a result of improvements in manufacturing and increasing competition, opening them out to an extensive patient base.
  • Improved patient education and awareness campaigns lead to faster heart valve disease detection and treatment, which may boost demand for prosthetic heart valves.

Roadblocks Faced by Prosthetic Heart Valve Manufacturers

  • The high price of devices may limit market growth for prosthetic heart valves and present a barrier to access for particular patients and healthcare systems.
  • The prosthetic heart valve market is competitive with multiple well-established firms and recent entrants. While competition can spur innovations in artificial cardiac valve devices, it can be difficult for smaller businesses to establish a presence in the prosthetic heart valve industry.
  • Rapid developments in medical technology, such as the creation of less intrusive valves, have the potential to render present goods outdated and necessitate a sizable investment in research and development to remain current with the prosthetic heart valve demand.

Healthcare delivery and pricing structures are continually changing. Manufacturers of prosthetic heart valves must adjust to changing economic situations, payment policies, and healthcare delivery paradigms

Comparative View of Adjacent Prosthetic Heart Valve Market

The transcatheter heart valve replacement market and the cardiac surgery devices market have both been studied by Future Market Insights (FMI). The data depict the projected market growth for prosthetic heart valves from 2023 to 2033 concerning other markets. It showcases the potential for revenue in the additional markets shown below.

Prosthetic Heart Valve Market:

Attributes Prosthetic Heart Valve Market
Value-based CAGR (2023 to 2033) 7.5%
Projected Market Value (2033) US$ 27,277.6 million
Market Trends
  • An aging population is a significant factor in the increase in demand for prosthetic heart valves.
  • Increased research and development investments are made for the prosthetic heart valve market.
Growth Factors
  • Minimally invasive techniques are shaping prosthetic heart valve sales.
  • The artificial heart valve market is seeing an increase in demand for transcatheter heart valves.

Transcatheter Heart Valve Replacement (TAVR) Market:

Attributes Transcatheter Heart Valve Replacement (TAVR) Market
Value-based CAGR (2023 to 2033) 14.8%
Projected Market Value (2033) US$ 26.02 billion
Market Trends
  • The aging population is the key reason for the TAVR market expansion.
  • There is an increase in transcatheter heart valve replacement techniques that are minimally invasive.
Growth Factors
  • Ongoing improvements to transcatheter heart valve replacement materials and construction.

Cardiac Surgery Devices Market:

Attributes Cardiac Surgery Devices Market
Value-based CAGR (2023 to 2033) 3.6%
Projected Market Value (2033) US$ 2.51 billion
Market Trends
  • The adoption of minimally invasive techniques in cardiac surgery is developing.
  • Hybrid operating rooms are becoming more in demand.
Growth Factors
  • Telemedicine is becoming more prevalent in post-operative care.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Outlook

An extensive artificial heart valve market segmentation evaluation sums up this part of the study. The prosthetic heart valve providers are paying more significant consideration to market trends in heart valve prosthetics and demand for biological/tissue heart valves. The hospital segment monopolizes the end-user category of the prosthetic heart valve demand.

The Biological or Tissue Heart Valve Segment Boom in Research and Development

Biological or tissue heart valves continue to be in high demand in the prosthetic heart valve sector. The biological or tissue heart valves provide a more natural and biocompatible option to reduce the risk of blood clot development and the requirement for long-term anticoagulant therapy.

A significant factor in the continued demand for tissue heart valves is the aging global population and the rising prevalence of cardiac disorders. The longevity and lower incidence of problems with biological valves make them a preferred choice for older patients who frequently need valve replacement.

Leading Segment Biological/Tissue Heart Valves
Segment Share 42.3%

Biological heart valves are a more reliable long-term solution owing to improved tissue engineering and preservation procedures that have increased their durability and performance. The strong demand for biological heart valves in the prosthetic heart valve devices market results from the field's ongoing research and development activities, which are helping to broaden their applications.

Patient Preference and the Hospital Segment's Growth in Prosthetic Heart Valve Treatments

The hospitals are the dominant end user, accounting for a substantial 75.6% market share of prosthetic heart valves. The hospital sector has a priceless infrastructure that includes advanced medical equipment, modern surgical facilities, and a variety of diagnostic instruments, producing a setting favorable to challenging cardiac treatments.

Leading Segment Hospitals
Segment Share 75.6%

The choice of patients to receive their treatments in hospitals is fueling the expansion of the hospital segment. Hospitals are the first choice of people seeking prosthetic heart valve treatments due to their excellent reputation, accessibility, and wide range of healthcare services. Between 2023 and 2033, the hospital sector has the opportunity to keep control of the prosthetic heart valve demand.

Country-wise Analysis

This part examines an exhaustive market analysis with data about various nations. In North America, Europe, and Asia Pacific, prosthetic heart valve sales are strengthening. North America has been developing steadily, followed by Europe, but prosthetic heart valve manufacturers possess ample opportunity in Asia Pacific.

Dominance of the Prosthetic Heart Valve Market in North America

  • Due to its extensive healthcare system and high frequency of heart disorders, the United States dominates the North America prosthetic heart valve market.
  • An older population and rising heart health awareness contribute to Canada's steady market growth of prosthetic heart valves.
Attributes Details
United States - Market Share 36%
  • Regulatory changes and reimbursement rules in the United States affect the prosthetic heart valve market outlook.
  • Canadian healthcare providers are progressively implementing advanced prosthetic heart valve technologies to improve patient outcomes.
  • Patient preferences for minimally invasive procedures are influencing trends in the adoption of prosthetic heart valves in North America.

Future Prospects of the Europe Market of Prosthetic Heart Valve

  • Germany manufacturers of medical devices dominate the Europe market.
  • The prosthetic heart valve market in the United Kingdom is driven by an aging population and increased valvular disease patients.
Attributes Details
Germany - Market Share 8.8%
United Kingdom - Market CAGR 12.4%
  • Italy's market is expanding due to the adoption of innovative surgical methods and upgraded medical facilities.
  • Europe's strict laws and payment practices considerably influence the prosthetic heart valve industry.
  • Partnerships between European healthcare facilities and prosthetic heart valve producers promote innovation and product development.

Government Initiatives Transforming Prosthetic Heart Valve Sector in Asia Pacific

  • The aging population in China and technological medical breakthroughs are forcing the rapid growth of China's prosthetic heart valve market.
  • Cost-effective prosthetic heart valves are in demand in India, which reflects the nation's sensitivity to healthcare costs.
Attributes Details
Japan - Market Share 5.8%
China - Market CAGR 12.5%
India - Market CAGR 12.2%
  • Much attention is paid to research and development for next-generation valve technology in Japan's prosthetic heart valve business.
  • Government healthcare programs in China and India are expanding access to treatments for prosthetic heart valves.
  • Manufacturers of prosthetic heart valves have numerous potential opportunities in the emerging markets of Asia Pacific.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Analysis

Due to the aging population and the increased prevalence of cardiac illnesses, there is fierce rivalry in the sales of prosthetic heart valves. Prominent prosthetic heart valve manufacturers dominate the industry with a broad selection of products. Key research areas include advancements in biocompatibility, robustness, and minimally invasive methods.

New prosthetic heart valve suppliers are introducing modern technologies, and expanding markets in the Asia Pacific have room for expansion. Critical market share variables for prosthetic heart valves include cost-effectiveness, regulatory approvals, and market penetration techniques. The intense competition encourages constant innovations in artificial cardiac valve devices and better patient results.

Recent Advancements

Company Details
The Approval to Edwards Lifesciences The MITRIS RESILIA valve was approved by the United States Food and Drug Administration (FDA) in March 2022. It is a tissue valve replacement made especially for the mitral location of the heart.
Jenavalve Technology, Inc. formed a Strategic Investment with Peijia Medical Limited. With the Chinese company Peijia Medical Limited, JenaValve Technology, Inc. engaged in a strategic investment and exclusive technology licensing deal in January 2022. In return for exclusive rights to create and market JenaValve's cutting-edge Trilogy TAVR systems in the Greater China region to treat patients with either severe symptomatic aortic regurgitation (AR) or severe symptomatic aortic stenosis, Peijia has invested cash and equity in JenaValve and continues to do so.
FDA Approval for Abbott For its Epic Plus and Epic Plus Supra Stended Tissue Valves, Abbott received FDA approval in 2021. The approval could be helpful in the management of mitral and aortic valve diseases.
Spectrum Health and Medtronic Plc Made the Partnership Announcement To add value to healthcare and improve outcomes for Spectrum Health patients, Medtronic plc and Spectrum Health inked a collaboration agreement in 2021.

Key Prosthetic Heart Valve Manufacturers

  • Edward Lifesciences Corporation
  • St. Jude Medical, Inc.
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • SYMETIS
  • LivaNova PLC
  • CryoLife, Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology, Inc.
  • Microinterventional Devices
  • Autotissue Berlin Gmbh
  • Meril Lifesciences
  • Comed B.V.

Key Segments

By Product:

  • Mechanical Heart Valves
    • Mechanical Aortic Valve
    • Mechanical Mitral Valve
  • Biological/Tissue Heart Valves
    • Tissue Aortic Valve
    • Tissue Mitral Valve
  • Transcatheter Heart Valves
    • Transcatheter Aortic Valve
    • Transcatheter Mitral Valve

By End User:

  • Hospitals
  • Ambulatory Services

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Current Prosthetic Heart Valve Market Valuation?

The market to secure a valuation of US$ 13,234.9 million in 2023.

How Big Can the Prosthetic Heart Valve Market Be by 2033?

The market is estimated to reach US$ 27,277.6 million by 2033.

What is the Growth Potential of the Prosthetic Heart Valve Market?

Through 2033, the industry is anticipated to expand at a 7.5% CAGR.

What Was the Historical Outlook of The Prosthetic Heart Valve Market?

From 2018 to 2022, the sales of prosthetic heart valves registered an 11.9% CAGR.

Which Product Type Segment to Dominate in the Prosthetic Heart Valve Market?

The biological/tissue heart valve sector is set to achieve a 42.3% market share.

Which End-user Segment to Lead the Prosthetic Heart Valve Market?

A 75.6% market share is expected for the hospital sector.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Mechanical Heart Valves

            5.3.1.1. Mechanical Aortic Valve

            5.3.1.2. Mechanical Mitral Valve

        5.3.2. Biological/Tissue Heart Valves

            5.3.2.1. Tissue Aortic Valve

            5.3.2.2. Tissue Mitral Valve

        5.3.3. Transcatheter Heart Valves

            5.3.3.1. Transcatheter Aortic Valve

            5.3.3.2. Transcatheter Mitral Valve

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Ambulatory Services

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1.USA

            8.2.1.2. Canada

        8.2.2. By Product

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By End User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2.UK

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Product

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By End User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Product

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Product

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Product

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product

            15.4.2.2. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product

            15.5.2.2. By End User

    15.6.UK

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product

            15.6.2.2. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product

            15.8.2.2. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product

            15.9.2.2. By End User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product

            15.11.2.2. By End User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product

            15.12.2.2. By End User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product

            15.13.2.2. By End User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product

            15.14.2.2. By End User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product

            15.15.2.2. By End User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product

            15.16.2.2. By End User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product

            15.17.2.2. By End User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Product

            15.18.2.2. By End User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Product

            15.19.2.2. By End User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Product

            15.20.2.2. By End User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Product

            15.21.2.2. By End User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Product

            15.22.2.2. By End User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Product

            15.23.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Edward Lifesciences Corporation

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. St. Jude Medical, Inc

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Medtronic plc

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Boston Scientific Corporation

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Abbott Laboratories

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. SYMETIS

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. LivaNova PLC

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. CryoLife, Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Braile Biomedica

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Colibri Heart Valve LLC

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Transcatheter Heart Valve Replacement Market

Published : February 2023

Healthcare

Cardiac Surgery Devices Market

Published : October 2022

Explore Healthcare Insights

View Reports

Prosthetic Heart Valve Market